US8940718 — Antiviral compounds
Method of Use · Assigned to Gilead Pharmasset LLC · Expires 2032-11-16 · 6y remaining
What this patent protects
This patent protects antiviral compounds, compositions containing them, and therapeutic methods using these compounds, as well as processes and intermediates for preparing the compounds.
USPTO Abstract
The disclosure is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
Drugs covered by this patent
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1470 |
— | |
U-1470 |
— | |
U-1470 |
— | |
U-1470 |
— | |
U-2039 |
— |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.